| Authors: |
Foster M; Science Applications International Corporation (SAIC), Reston, VA 20190, USA., Negash Y; Science Applications International Corporation (SAIC), Reston, VA 20190, USA., Eberhardt L; Science Applications International Corporation (SAIC), Reston, VA 20190, USA., Bryan WW; Office of Tissues and Advanced Therapies (OTAT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, USA., Schultz K; Office of Tissues and Advanced Therapies (OTAT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, USA., Wang X; Office of Tissues and Advanced Therapies (OTAT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, USA., Xu Y; Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, USA., George B; Office of Tissues and Advanced Therapies (OTAT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Silver Spring, MD 20993, USA. |
